Search Within

Michael Morris

Formats
  1. Meeting Abstract (276)
  2. Journal Article (268)
  3. Review (21)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (588)
  2. Genitourinary Oncology Service (588)
  3. Solid Tumor Oncology Division (588)
  4. Radiology, Department of (165)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (142)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (29)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (45)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (45)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (588)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial results of PCK3145 in patients (pts) with castrate metastatic prostate cancer (PC) - The US experience
    Meeting Abstract

    Slovin, S. F.; Daigneault, L.; Dulude, H.; Panchal, C.; Richardson, J.; Curley, T.; Delacruz, A.; Fleisher, M.; Morris, M.; Scher, H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase 2 trial of (177)Lutetium (Lu-177) radiolabeled anti-prostate-specific membrane antigen (PSMA) monoclonal antibody (mAb) J591 (Lu-177-J591) in patients (pts) with metastatic androgen-independent prostate cancer (AIPC)
    Meeting Abstract

    Morris, M. J.; Milowsky, M. I.; Pandit-Taskar, N.; Divgi, C.; David, K. A.; Rozario, C. P.; Vallabhajosula, S.; Goldsmith, S. J.; Scher, H. I.; Nanus, D. M.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Correlative results of in-vivo monitoring of platelet-derived growth factor receptor (PDGFR) activation status in a randomized placebo-controlled trial of docetaxel +/- imatinib in castration-resistant prostate cancer (CRPC) and bone metastases (BM)
    Meeting Abstract

    Mathew, P.; Thall, P. F.; Wen, S.; Horne, E.; Johnson, M.; Oh, W. K.; Morris, M. J.; Logothetis, C. J.; Fidler, I. J.; Bucana, C.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Preliminary results of a randomized placebo-controlled,double-blind trial of weekly docetaxel combined with imatinib in men with metastatic androgen-independent prostate cancer (AIPC) and bone metastases (BM)
    Meeting Abstract

    Mathew, P.; Thall, P. F.; Johnson, M. M.; Oh, W. K.; Meluch, A. A.; Morris, M. J.; Troncoso, P.; Bucana, C. D.; Fidler, I. J.; Logothetis, C. J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Paclitaxel and carboplatin versus mitoxantrone: Lessons of an underpowered study: Commentary
    Journal Article

    Morris, M. J.
    Nature Clinical Practice Oncology (2006)

    Fulltext@MSK | Save
  • Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
    Journal Article

    Fleming, M. T.; Morris, M. J.; Heller, G.; Scher, H. I.
    Nature Clinical Practice Oncology (2006)

    Fulltext@MSK | Save
  • Rapid androgen cycling as treatment for patients with prostate cancer
    Journal Article

    Feltquate, D.; Nordquist, L.; Eicher, C.; Morris, M.; Smaletz, O.; Slovin, S.; Curley, T.; Wilton, A.; Fleisher, M.; Heller, G.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The men's cycle plus docetaxel (Doc) in prostate cancer patients with rising PSAs in the non-castrate state
    Meeting Abstract

    Slovin, S. F.; Carducci, M. A.; Beekman, K. W.; Pili, R.; Eicher, C.; Kelly, W. K.; Morris, M. J.; Shaffer, D.; Eisenberger, M.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save